Search

Mason M Yamashita

age ~61

from San Diego, CA

Also known as:
  • Mason Elaine Yamashita
  • Mason A
Phone and address:
3626 Torrey View Ct, San Diego, CA 92130
(619)3062125

Mason Yamashita Phones & Addresses

  • 3626 Torrey View Ct, San Diego, CA 92130 • (619)3062125
  • Clarence, NY
  • 14 Fort Washington Pl, Cambridge, MA 02139
  • La Jolla, CA
  • Honolulu, HI
  • Pearl City, HI

Work

  • Company:
    Isis pharmaceuticals
    Feb 2011
  • Position:
    Executive director, clinical development

Education

  • School / High School:
    University of Hawaii At Manoa
    1996

Skills

Clinical Development • Drug Safety

Languages

English

Industries

Biotechnology

Specialities

Psychiatry

Us Patents

  • Cancer Treatment

    view source
  • US Patent:
    20180346907, Dec 6, 2018
  • Filed:
    Nov 27, 2017
  • Appl. No.:
    15/822692
  • Inventors:
    - Carlsbad CA, US
    Mason YAMASHITA - Carlsbad CA, US
  • Assignee:
    Ionis Pharmaceuticals, Inc. - Carlsbad CA
  • International Classification:
    C12N 15/113
    C07K 14/47
  • Abstract:
    In certain embodiments, methods, compounds, and compositions for treating B-cell lymphoma or hepatocellular carcinoma by inhibiting expression of STAT3 mRNA or protein in an animal are provided herein. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate B-cell lymphoma or hepatocellular carcinoma.
  • Cancer Treatment

    view source
  • US Patent:
    20170145413, May 25, 2017
  • Filed:
    Nov 21, 2016
  • Appl. No.:
    15/356947
  • Inventors:
    - Carlsbad CA, US
    Mason YAMASHITA - Carlsbad CA, US
  • Assignee:
    Ionis Pharmaceuticals, Inc. - Carlsbad CA
  • International Classification:
    C12N 15/113
  • Abstract:
    In certain embodiments, methods, compounds, and compositions for treating B-cell lymphoma or hepatocellular carcinoma by inhibiting expression of ST AT3 mRNA or protein in an animal are provided herein. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate B-celllymphoma or hepatocellular carcinoma. The STAT (signal transducers and activators of transcription) family of proteins are DNA-binding proteins that play a dual role in signal transduction and activation of transcription.
  • Cancer Treatment

    view source
  • US Patent:
    20160002625, Jan 7, 2016
  • Filed:
    Oct 30, 2013
  • Appl. No.:
    14/439363
  • Inventors:
    - Carlsbad CA, US
    Mason YAMASHITA - Carlsbad CA, US
  • Assignee:
    ISIS PHARMACEUTICALS INC. - Carlsbad CA
  • International Classification:
    C12N 15/113
    C07K 14/47
  • Abstract:
    In certain embodiments, methods, compounds, and compositions for treating B-cell lymphoma or hepatocellular carcinoma by inhibiting expression of ST AT3 mRNA or protein in an animal are provided herein. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate B-cell lymphoma or hepatocellular carcinoma. The STAT (signal transducers and activators of transcription) family of proteins are DNA-binding proteins that play a dual role in signal transduction and activation of transcription.
Name / Title
Company / Classification
Phones & Addresses
Mason Masaki Yamashita
Mason Yamashita MD
Psychiatrist
10813 Cherry Hl Dr, San Diego, CA 92130

Medicine Doctors

Mason Yamashita Photo 1

Dr. Mason M Yamashita, Carlsbad CA - MD (Doctor of Medicine)

view source
Specialties:
Psychiatry
Address:
1896 Rutherford Rd, Carlsbad, CA 92008
Languages:
English
Education:
Medical School
University of Hawaii At Manoa
Graduated: 1996
Mason Yamashita Photo 2

Mason Masaki Yamashita

view source
Specialties:
Internal Medicine
Psychiatry
Education:
University of Hawaii (1996)

Resumes

Mason Yamashita Photo 3

Vice President, Pharmacovigilance

view source
Location:
San Diego, CA
Industry:
Biotechnology
Work:
Isis Pharmaceuticals since Feb 2011
Executive Director, Clinical Development

Ambit Biosciences Aug 2010 - Feb 2011
Senior Director, Clinical Development

Biogen Idec Dec 2008 - Aug 2010
Medical Director, Drug Safety

Biogen Idec Feb 2007 - Dec 2008
Associate Director, Drug Safety

Neurocrine Biosciences 2005 - 2007
Assoc Medical Director
Education:
University of Hawaii John A. Burns School of Medicine 1992 - 1996
MD, Medicine
University of California, Los Angeles 1985 - 1989
PhD, Physical Chemistry
Skills:
Clinical Development
Drug Safety

Get Report for Mason M Yamashita from San Diego, CA, age ~61
Control profile